Primary Hemostasis

Screening for thrombocytopathy, whether systemic or acquired.
Biological monitoring of anti-platelet therapy.

Reference	Registration	Presentation
AG001K	CE-IVD	3 x 0.1 µmol

IFU APPLICATION SDS COT TABLE OF ASSIGNED VALUE

Arachidonic Acid

Screening for thrombocytopathy, whether systemic or acquired.
Biological monitoring of anti-platelet therapy.

Reference	Registration	Presentation
AG003K	CE-IVD	3 x 7.5 µmol

IFU APPLICATION SDS COT TABLE OF ASSIGNED VALUE

Epinephrine

Screening for thrombocytopathy, whether systemic or acquired.
Biological monitoring of anti-platelet therapy.

Reference	Registration	Presentation
AG002K	CE-IVD	3 x 0.5 µmol

IFU APPLICATION SDS COT TABLE OF ASSIGNED VALUE

Collagen

Detection of constitutional thrombocytopathy or acquired thrombocytopathy.
Biological monitoring of anti-platelet therapy.

Reference	Registration	Presentation
AG005K	CE-IVD	R1 : 3 x 0.5 mg R2: 3 x 12 mL

IFU APPLICATION SDS COT TABLE OF ASSIGNED VALUE

Ristocetin

For Ristocetin-Induced Platelet Aggregation (RIPA) tests. To detect von Willebrand disease, more specifically to highlight an increased affinity of von Willebrand Factor (vWF) for GPIb in type 2B and to identify Bernard-Soulier syndrome.

Reference	Registration	Presentation
AG004K	CE-IVD	3 x 7.5 mg

IFU APPLICATION SDS COT TABLE OF ASSIGNED VALUE

Lyophilized Platelets

Platelets for Ristocetin cofactor activity assay (vWF:RCo).

Reference	Registration	Presentation
AG006K on-demand	CE-IVD	R1: 3 x 5 mL R2: 3 x 5 mL

IFU APPLICATION SDS COT TABLE OF ASSIGNED VALUE

LIAPHEN™ vWF: Ag

Liquid and Ready to use

Determination of von Willebrand Factor Antigen (vWF: Ag), in human citrated plasma with a Latex turbidimetric assay.

Reference	Registration	Presentation
120206	CE-IVD	R1: 4 x 5 mL R2: 4 x 6 mL

IFU APPLICATION SDS COT TABLE OF ASSIGNED VALUE

ZYMUTEST™ vWF

Determination of von Willebrand Factor (vWF) in human plasma with an Elisa method.

Reference	Registration	Presentation
RK030A	CE-IVD	96 tests

IFU APPLICATION SDS COT TABLE OF ASSIGNED VALUE

ZYMUTEST™ vWF:CBA

Determination of human von Willebrand Factor (vWF) Collagen Binding Activity (CBA) in human plasma.

Reference	Registration	Presentation
RK038A	CE-IVD	96 tests

IFU APPLICATION SDS COT TABLE OF ASSIGNED VALUE

vWF Deficient Plasma

For any study or research protocol where a source of human vWF deficient plasma is required. This plasma is also FVIII deficient.

Reference	Registration	Presentation
DP150K	RUO	6 x 1 mL

IFU APPLICATION SDS COT TABLE OF ASSIGNED VALUE

ZYMUTEST™ PF4

Measurement of human Platelet Factor 4 (PF4) by Elisa in platelet depleted plasma.

Reference	Registration	Presentation
RK006A	RUO	96 tests

IFU APPLICATION SDS COT TABLE OF ASSIGNED VALUE

See all the categories

rgpd_choix	0	Site web	Politique de confidentialité
rgpd_lg	fr	Site web	Politique de confidentialité

WE RESPECT YOUR PRIVACY!

Primary Hemostasis